Specialists for B-cell prolymphocytic leukemia
29 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.
ℹ
Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.
Report missing data- Sumithira Vasu, MD, M.DRare Disease / Clinical ResearchOhio State University Comprehensive Cancer CenterCOLUMBUS, OHQC-verified PI×4
- David MaloneyRare Disease / Clinical ResearchFred Hutchinson Cancer Research Center/University of Washington Cancer ConsortiumPI×11
- Colleen Delaney, MDRare Disease / Clinical ResearchFred Hutchinson Cancer Research Center/University of Washington Cancer ConsortiumOLD GREENWICH, CTPI×3
- Ryotaro NakamuraRare Disease SpecialistCity of Hope Medical CenterDuarte, CaliforniaPI×6
- Steven Devine, MD, MDRare Disease / Clinical ResearchNMDPLA CROSSE, WIPI×4
- Nancy Wells, DNSc, RNRare Disease / Clinical ResearchVanderbilt-Ingram Cancer CenterPI×2
- Elizabeth Fox, MDRare Disease / Clinical ResearchNational Cancer Institute (NCI)PI×5
- Claudio G. Brunstein, MD, PhD, M.D., PhDRare Disease / Clinical ResearchMasonic Cancer Center, University of MinnesotaMINNEAPOLIS, MNPI×6
- Kami Maddocks, MD, MDRare Disease / Clinical ResearchOhio State UniversityCOLUMBUS, OHPI×5
- Chitra Hosing, M.DRare Disease / Clinical ResearchM.D. Anderson Cancer CenterHOUSTON, TXPI×5
- John C Reneau, MD, MDRare Disease / Clinical ResearchOhio State University Comprehensive Cancer CenterLAS VEGAS, NVPI×1
- Jennifer Woyach, MD, MDRare Disease / Clinical ResearchOhio State University Comprehensive Cancer CenterCOLUMBUS, OHPI×3
- Mark J Roschewski, M.D., MDRare Disease / Clinical ResearchNational Cancer Institute (NCI)WASHINGTON, DCPI×6
- Margaret L. MacMillan, MDRare Disease / Clinical ResearchMasonic Cancer Center, University of MinnesotaPI×4
- Ann Woolfrey, M.DRare Disease / Clinical ResearchFred Hutchinson Cancer Research Center/University of Washington Cancer ConsortiumSEATTLE, WAPI×5
- Tom R. Fitch, M.D.Rare Disease / Clinical ResearchMayo ClinicGLENDALE, AZPI×1
- Scott R Solomon, MDRare Disease / Clinical ResearchBlood and Marrow Transplant Group of GeorgiaPI×4
- Susan O'Brien, MDRare Disease / Clinical ResearchM.D. Anderson Cancer CenterPI×2
- Paul Armistead, MD, M.D., PhDRare Disease / Clinical ResearchUNC Lineberger Comprehensive Cancer CenterCHAPEL HILL, NCPI×1
- Chet Bohac, PharmD, MD, MScRare Disease / Clinical ResearchExecutive Medical Director, Clinical Development, Xencor, Inc.PI×1
- Robert Kreitman, MPNational Cancer Institute (NCI)OLNEY, MDQC-verified PI×5
- Jeffrey JonesOhio State UniversityQC-verified PI×2
- Bernard J. Silver, M.DUniversity Hospitals Seidman Cancer CenterCLEVELAND, OHQC-verified PI×1
- Judy PoehlmanPharmatech OncologyQC-verified PI×1
- Daniel A Pollyea, MDUniversity of Colorado, DenverAURORA, COQC-verified PI×1
- Thomas LinOhio State UniversityQC-verified PI×2
- Luis Isola, MDIcahn School of Medicine at Mount SinaiNEW YORK, NYQC-verified PI×1
- William G. Wierda, M.D., PhDM.D. Anderson Cancer CenterHOUSTON, TXQC-verified PI×5
- Michael Herold, LPCHELIOS Hospital, Erfurt, GermanyQC-verified PI×1